VeriMomlavandula angustifolia flower oil est-il sûr pendant la grossesse ?
No EU Annex II/III listing or harmonised CLP classification was found (no H360/H361/H codes). Case reports and in vitro assays report estrogenic/anti‑androgenic activity linked to lavender oil components (Henley NEJM 2007; J Clin Endocrinol Metab review), but a well‑conducted in vivo uterotrophic percutaneous assay in immature rats found no estrogenic activity (Politano et al. 2013). Overall this places hazard at a low/theoretical level (h=1) with demonstrated in vitro mechanism evidence (m=2). Topical cosmetic exposure gives low but measurable systemic exposure (e=1). Sources: Henley 2007 (NEJM), J Clin Endocrinol Metab case series/assays, Politano 2013 uterotrophic negative, ECHA substance records, EWG entry.
Alternatives sûres à lavandula angustifolia flower oil pendant la grossesse | VeriMom
Related ingredients
Frequently asked questions
- lavandula angustifolia flower oil est-il sûr pendant la grossesse ?
- No EU Annex II/III listing or harmonised CLP classification was found (no H360/H361/H codes). Case reports and in vitro assays report estrogenic/anti‑androgenic activity linked to lavender oil components (Henley NEJM 2007; J Clin Endocrinol Metab review), but a well‑conducted in vivo uterotrophic percutaneous assay in immature rats found no estrogenic activity (Politano et al. 2013). Overall this places hazard at a low/theoretical level (h=1) with demonstrated in vitro mechanism evidence (m=2). Topical cosmetic exposure gives low but measurable systemic exposure (e=1). Sources: Henley 2007 (NEJM), J Clin Endocrinol Metab case series/assays, Politano 2013 uterotrophic negative, ECHA substance records, EWG entry.
- lavandula angustifolia flower oil est-il sûr pendant l'allaitement ?
- Same rationale as pregnancy: no harmonised classification or regulatory ban; mechanistic/in vitro signals exist but in vivo data do not confirm estrogenicity. Systemic absorption from topical use is low, so maternal exposure and transfer into breastmilk are possible but expected to be low from normal cosmetic use; therefore h=1, m=2, e=1.
- lavandula angustifolia flower oil est-il sûr pour la peau de bébé ?
- Hazard remains low/theoretical (h=1) because human case reports/in vitro activity exist but no harmonised classification or conclusive animal reproductive/teratogenic evidence. Mechanistic signals (estrogenic/anti‑androgenic activity in vitro) are documented (m=2). Exposure score is increased by +1 for infants (immature skin barrier, higher surface-to-weight ratio) giving e=2 for baby topical exposure. Additionally, lavender oil constituents (oxidized linalool) are recognised contact allergens—relevance for infant skin sensitization is separate from reproductive scoring.
- Comment VeriMom évalue-t-il lavandula angustifolia flower oil ?
- VeriMom évalue lavandula angustifolia flower oil à 60/100 (risque moyen) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à lavandula angustifolia flower oil pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à lavandula angustifolia flower oil basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.